Low-dose pembrolizumab for relapsed/refractory Hodgkin lymphoma: high efficacy with minimal toxicity.
Saved in:
| Title: | Low-dose pembrolizumab for relapsed/refractory Hodgkin lymphoma: high efficacy with minimal toxicity. |
|---|---|
| Authors: | Chan TS; Department of Medicine, Professorial Block, Queen Mary Hospital, Pokfulam Road, Hong Kong, China., Luk TH; Department of Medicine, Queen Elizabeth Hospital, Hong Kong, China., Lau JS; Department of Medicine, Queen Elizabeth Hospital, Hong Kong, China., Khong PL; Department of Diagnostic Radiology, Queen Mary Hospital, Hong Kong, China., Kwong YL; Department of Medicine, Professorial Block, Queen Mary Hospital, Pokfulam Road, Hong Kong, China. ylkwong@hkucc.hku.hk. |
| Source: | Annals of hematology [Ann Hematol] 2017 Apr; Vol. 96 (4), pp. 647-651. Date of Electronic Publication: 2017 Jan 31. |
| Publication Type: | Journal Article; Multicenter Study |
| Journal Info: | Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
